Singapore, Aug. 11 -- Bristol Myers Squibb (BMS) has announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus, representing an approximately $2.3 billion investment designed to accelerate the delivery of next-generation medicines to patients.

The campus, at Generation Park in Houston, will create nearly 500 skilled jobs and is designed to grow in scale, capability and workforce for decades to come.

The selection of Houston marks a significant milestone in BMS' $40 billion commitment to invest in the United States (US) over five years across research and development, technology and domestic manufacturing.

Its modular design allows BMS to add and reconfigure manufacturing capacit...